Natural Product Biosynthesis and Protein Kinase Inhibition

Natural product biosynthesis involves the enzymatic assembly of structurally complex small molecules by microorganisms, plants and marine organisms through orchestrated gene clusters encoding polyketide synthases, non-ribosomal peptide synthetases and other tailoring enzymes. These secondary metabolites include ansamycins, indolocarbazoles and other scaffold classes that interact with cellular kinases. Protein kinases catalyse phosphorylation of substrate proteins, regulating signalling cascades fundamental to cell growth, apoptosis and differentiation. Natural kinase inhibitors exploit unique binding pockets and allosteric sites to achieve high potency and selectivity. Advances in genomics, heterologous expression systems and biosynthetic engineering have expanded access to novel scaffolds, while crystallographic and biophysical analyses refine our understanding of inhibitor-kinase interactions. The convergence of biosynthetic research and kinase pharmacology underpins the discovery of new therapeutics for cancer, inflammatory and infectious diseases, demonstrating the global significance of these integrated disciplines.

Research from Nature Portfolio

Recent studies have elucidated how a TetR-family transcriptional regulator coordinates the biosynthesis of geldanamycin and elaiophylin in a Streptomyces strain. The regulator binds non-palindromic promoter sequences to activate ansamycin polyketide synthase genes while repressing a macrodiolide antibiotic cluster, revealing a molecular switch that synchronises divergent pathways. Structural mapping of DNA-protein interfaces has identified key nucleotides essential for selective binding, offering a blueprint for metabolic engineering to enhance production yields and generate novel analogue libraries.

Natural Product Biosynthesis and Protein Kinase Inhibition publication trend

The graph below shows the total number of articles in natural product biosynthesis and protein kinase inhibition across all publications each year (not limited to Nature Index journals).

Technical terms

Natural product biosynthesis: Enzymatic pathways in organisms that assemble complex secondary metabolites.

Protein kinase: Enzyme that transfers phosphate groups to protein substrates, modulating activity and signalling.

Transcriptional regulator: Protein that binds DNA to activate or repress gene expression.

Gene cluster: Co-localised set of genes encoding enzymes and regulators for a specific biosynthetic pathway.

Ansamycin: Class of polyketide antibiotics with an aromatic core bridged by an aliphatic “ansa” chain.

Indolocarbazole: Alkaloid scaffold characterised by a fused indole and carbazole ring system, often kinase-active.

Allosteric inhibitor: Compound that binds a regulatory site distinct from the active site to modulate enzyme function.

Structure-activity relationship (SAR): Analysis correlating chemical modifications of a molecule with changes in its biological activity.

References

1. A Systematic Review of Recently Reported Marine Derived Natural Product Kinase Inhibitors. Marine Drugs (2019).
2. GdmRIII, a TetR Family Transcriptional Regulator, Controls Geldanamycin and Elaiophylin Biosynthesis in Streptomyces autolyticus CGMCC0516. Scientific Reports (2017).
3. Marine-derived protein kinase inhibitors for neuroinflammatory diseases. BioMedical Engineering OnLine (2018).